Abstract:Background: Dendritic cell (DC) targeted antigen delivery is a promising strategy to enhance vaccine efficacy and delivery of therapeutics. Self-assembling peptide-based nanoparticles and virus-like particles (VLPs) have attracted extensive interest as non replicating vectors for nanovaccine design, based on their unique properties, including molecular specificity, biodegradability and biocompatibility. DCs are specialized antigen-presenting cells involved in antigen capture, processing, and presentation to initiate adaptive immune responses. Using DC-specific ligands for targeted delivery of antigens to DCs may be utilized as a promising strategy to drive efficient and strong immune responses. Methods: In this study, several candidates for DC-binding peptides (DCbps) were individually integrated into C-terminal of porcine circovirus type 2 (PCV2) Cap, a viral protein that could self-assemble into icosahedral VLPs with 60 subunits. The immunostimulatory adjuvant activity of DC-targeted VLPs was further evaluated in a vaccine model of PCV2 Cap. Results: With transmission electron microscopy (TEM), E. coli expressed Cap-DCbp fusion proteins were observed self-assembled into highly ordered VLPs. Further, in dynamic light scattering (DLS) analysis, chimeric VLPs exhibited similar particle size uniformity and narrow size distribution as compared to wild type Cap VLPs. With a distinctly higher targeting efficiency, DCbp3 integrated Cap VLPs (Cap-DCbp3) displayed enhanced antigen uptake and increased elicitation of antigen presentation-related factors in BM-DCs. Mice subcutaneously immunized with Cap-DCbp3 VLPs exhibited significantly higher levels of Cap-specific antibodies, neutralizing antibodies and intracellular cytokines than those with other DCbp integrated or wild type Cap VLPs without any DCbp. Interestingly, Cap-DCbp3 VLPs vaccine induces robust cellular immune response profile, including the efficient production of IFN-gamma, IL-2 and IL-10. Meanwhile, the improved proliferation index in lymphocytes with Cap-DCbp3 was also detected as compared to other VLPs. Conclusion: This study described the potential of DC-binding peptides for further improved antigen delivery and vaccine efficacy, explainning nanovaccine optimization in relation to a range of emerging and circulating infectious pathogens.

Selection of Affinity Peptides for the Purification Potential of Porcine Circovirus Type 2 (pcv2) Cap Virus-Like Particles (Vlps)

Design and Preliminary Application of Affinity Peptide Based on the Structure of the Porcine Circovirus Type II Capsid (PCV2 Cap)

Characterization and potential use of truncated PCV2 capsid protein and its polyclonal antibody for diagnosis of PCV2 infections.

Specific Ligands for Classical Swine Fever Virus Screened from Landscape Phage Display Library.

Establishment of the Multiplex PCR for Detection of Porcine Circovirus

Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2.

Self-assembly into virus–like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection

[Antigenic Analysis of the Recombinant Capsid Protein of Porcine Circovirus Type 2].

Immunogenicity Analysis of PCV3 Recombinant Capsid Protein Virus-like Particles and Their Application in Antibodies Detection

Fine Mapping Of Antigenic Epitopes On Capsid Proteins Of Porcine Circovirus, And Antigenic Phenotype Of Porcine Circovirus Type 2

Fine mapping of linear B cell epitopes on capsid protein of porcine circovirus 3

Expression and immunogenicity analysis of the capsid proteins of porcine circovirus types 2 to 4

Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection

Identification of a Conserved B-Cell Epitope on the Capsid Protein of Porcine Circovirus Type 4

In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal.

Targeted Delivery of Nanovaccine to Dendritic Cells Via DC-Binding Peptides Induces Potent Antiviral Immunity in Vivo

Development a high-sensitivity sandwich ELISA for determining antigen content of porcine circovirus type 2 vaccines

Integrated System for Purification and Assembly of PCV Cap Nano Vaccine Based on Targeting Peptide Ligand

Expression and self-assembly of virus-like particles from porcine parvovirus and its application in antibody detection

Prediction and Identification of B Cell Epitopes of the PCV2 Cap Protein

Development of Gold Immunochromatographic Assay Strip Based on Specific Polyclonal Antibodies Against Capsid Protein for Rapid Detection of Porcine Circovirus 2 in Zhejiang Province, China